Adverse Outcomes Continue In Novel Program For Malaria In Pregnancy

In sub-Saharan Africa a novel strategy to screen pregnant women for malaria with rapid diagnostic tests does not seem to lower the risk of adverse pregnancy outcomes.

In an open label randomized trial published in PLOS Medicine by Feiko ter Kuile, of the Liverpool School of Tropical Medicine, antimalarials were compared with treating all pregnant women with the malaria preventive sulfadoxine-pyrimethamine (SP).

Malaria - Causes, Symptoms, Diagnosis, Prevention, Treatment
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is characterized by fever, vomiting, shivering, sweating and other symptoms.

During pregnancy, undetected infection with malaria parasites can lead to maternal anemia, low birthweight, and fetal loss. In areas where malaria is endemic, the World Health Organization recommends treating pregnant women with SP, but in some areas, more than 90 percent of Plasmodium parasites are resistant to SP.

In the new study, the researchers compared this standard of care to a screening approach where pregnant women are tested approximately monthly for malaria using rapid diagnostic tests and treated with a different drug, dihydroartemisinin-piperaquine (DP) only if they test positive for the parasite.

The study, which randomly assigned 1873 HIV-negative pregnant women at three sites in Malawi to receive either strategy, found that the risks of adverse birth outcomes, at 29.9 and 28.8 percent, was similar in the two groups.

Early Signs of Pregnancy | Pregnancy - Early Signs
Pregnant or not pregnant? Catch on to the early pregnancy signs and symptoms and replace suspense with relief.

However, the prevalence of malaria at delivery was higher in the rapid screening and DP group, at 48.7 percent, compared to 40.8 percent in the SP group (relative risk=1.19 [95% confidence interval 1.07-1.33], p=0.007), meaning an additional 8 out of every 100 pregnancies would be affected by malaria using this approach compared to broad prevention using SP.

Moreover, the rate of fetal loss was 2.6 percent, double the rate of 1.3 percent seen among women who took intermittent doses of SP (relative risk=2.06 [1.01-4.21], p=0.046). The current results, however, may not hold true in all areas because risk of malaria transmission varies according to location, as does parasite resistance to drugs.

Anemia in Pregnancy - Causes Prevention Symptoms Diagnosis Treatment
Anemia is the commonest blood disorder that may occur in pregnancy and is usually due to low iron or folate reserves of the body and this is reflected as anemia.

In addition, the study design did not investigate the outcomes of using monthly DP for prevention without coupling it to screening.

"These results suggest that [intermittent screening and treatment with DP] may not be a suitable alternative strategy to replace [intermittent preventive therapy with SP] in settings similar to ours and may even predispose to unfavorable pregnancy outcomes in these settings," the authors say.

Healthy Weight Gain during Pregnancy
Recommended weight gain during pregnancy is determined as per pre-pregnancy weight and BMI. Healthy weight gain is very important for pregnancy health and is achieved with the right diet and exercise.

Source-Eurekalert